Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

March 31, 2025 07:00 ET | Source: BioStem Technologies, Inc.

BioStem Announces Notice of Allowance for Two U.S. Patent Applications

BioStem Announces Notice of Allowance for Two U.S. Patent Applications
March 27, 2025 07:00 ET | Source: BioStem Technologies, Inc.

BioStem Technologies to Present at the 24th Annual Needham Virtual Healthcare Conference

BioStem Technologies to Present at the 24th Annual Needham Virtual Healthcare Conference
February 24, 2025 07:00 ET | Source: BioStem Technologies, Inc.

BioStem Receives Institutional Review Board (IRB) Approval to Advance Clinical Trial Demonstrating the Therapeutic Benefits of BioREtain® Technology in Treating Venous Leg Ulcers

BioStem Receives Institutional Review Board (IRB) Approval to Advance Clinical Trial Demonstrating the Therapeutic Benefits of BioREtain® Technology
January 13, 2025 07:00 ET | Source: BioStem Technologies, Inc.

BioStem Technologies Announces Record Preliminary Fourth Quarter Net Revenue of $102.9 Million, with Full-Year 2024 Net Revenue Expected to Reach $301.8 Million

BioStem Technologies Announces Record Preliminary Fourth Quarter Net Revenue of $102.9 Million, with Full-Year 2024 Net Revenue Expected to Reach $301.8 M
January 08, 2025 07:00 ET | Source: BioStem Technologies, Inc.

BioStem Technologies Launches Clinical Trial to Demonstrate the Therapeutic Benefits of its BioREtain® Technology in Treating Diabetic Foot Ulcers Using Vendaje®

BioStem Technologies Launches Clinical Trial to Demonstrate the Therapeutic Benefits of its BioREtain® Technology
January 02, 2025 07:00 ET | Source: BioStem Technologies, Inc.

BioStem Technologies CEO to Present at Biotech Showcase 2025

BioStem Technologies CEO to Present at Biotech Showcase 2025
November 25, 2024 07:00 ET | Source: BioStem Technologies, Inc.

BioStem Announces Notice of Allowance for U.S. Patent Application for Sterile Human Placental Allografts

BioStem Announces Notice of Allowance for U.S. Patent Application for Sterile Human Placental Allografts
November 20, 2024 07:00 ET | Source: BioStem Technologies, Inc.

BioStem Technologies Signs Letter of Intent to Acquire Wound Care Products and Technologies from ProgenaCare Global

BioStem Technologies Signs Letter of Intent to Acquire Wound Care Products and Technologies from ProgenaCare Global
November 12, 2024 07:29 ET | Source: BioStem Technologies, Inc.

BioStem Technologies Reports Record Third Quarter 2024 Revenue of $82.6 Million

BioStem Technologies Reports Record Third Quarter 2024 Revenue of $82.6 Million
October 29, 2024 07:00 ET | Source: BioStem Technologies, Inc.

BioStem Technologies Initiates Nationwide Launch of Vendaje AC® with Venture Medical Following Established Reimbursement in All Medicare Administrative Contractor (MAC) Regions

BioStem Technologies Initiates Nationwide Launch of Vendaje AC® with Venture Medical Following Established Reimbursement in All MAC Regions